Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank

OBJECTIVE: The Early Treatment of Atrial Fibrillation for Stroke Prevention (EAST-AFNET4) trial showed a clinical benefit of early rhythm-control therapy in patients with recently diagnosed atrial fibrillation (AF). The generalisability of the results in the general population is not known. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kany, Shinwan, Cardoso, Victor Roth, Bravo, Laura, Williams, John A, Schnabel, Renate, Fabritz, Larissa, Gkoutos, Georgios V, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664114/
https://www.ncbi.nlm.nih.gov/pubmed/35835543
http://dx.doi.org/10.1136/heartjnl-2022-321196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664114/
https://www.ncbi.nlm.nih.gov/pubmed/35835543
http://dx.doi.org/10.1136/heartjnl-2022-321196

Ejemplares similares